Salmeterol
Long-Acting β2 Agonist (LABA)- Drug Class
- Long-Acting β2 Agonist (LABA)
- Mechanism of Action (MOA)
- Long-acting β2-adrenergic agonist → sustained bronchodilation.
- Black Box Warning
- Asthma-related death when used as monotherapy — in asthma, use only combined with an inhaled corticosteroid.
- Clinical Notes
- Always pair with an ICS in asthma; LABA monotherapy is acceptable in COPD. Not a rescue inhaler.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Used for
Same family
Got a pharmacology lecture that covers Salmeterol? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology